Lin, Hui-Ming
Garvan Institute of Medical Research · UNSW Sydney
2 papers on CoChatORCID 0000-0003-4892-6008
Most cited papers
- Verified
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Scheinberg, T., Lin, H.-M., Fitzpatrick, M., Azad, A. A., Bonnitcha, P., Davies, A., Heller, G., Huynh, K., Mak, B., Mahon, K., et al. (2024) · Prostate Cancer and Prostatic Diseases
Cancer, Lipids, and MetabolismProstate Cancer Treatment and Research
Cited by 15
- Verified
P2.04-90 Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung Cancer
Sepesi, B., Godoy, M., William, W., Vaporciyan, A., Lin, H., Leung, C., Lee, J., Mitchell, K., Weissferdt, A., Le, X., et al. (2019) · Journal of Thoracic Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free